This article by Christopher Lane has been published in Psychology Today. It begins:
“With more than 13.2 percent of the adult U.S. population monthly filling prescriptions for SSRI antidepressants, a figure involving at least 45 million Americans, it is disconcerting to find multiple studies conclude SSRIs ‘may cause sexual dysfunction in 40 to 65 percent of individuals’ prescribed them. Some put the incidence rate as high as 72.7 percent (2001) and 81.4 percent (1997).
Drug-makers and regulators have long known about the condition, first known as ‘Antidepressant-induced sexual dysfunction.’ The U.K.’s Medicines and Healthcare products Regulatory Agency (MHRA) began noting reports of sexual dysfunction after an SSRI was withdrawn in 1987, with fluvoxamine (Luvox) followed in 1991 by fluoxetine (Prozac).
Subsequent studies—including one in 2001 involving 1,022 outpatients—concluded that citalopram (Celexa) had a still-higher incidence rate at 72.7 percent, with paroxetine (Paxil) a close second at 70.7 percent …”
You can read more from here.
